ClinicalTrials.Veeva

Find clinical trials for Breast Cancer in Roma, Lazio

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near Roma, Lazio, ITA:

CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast Cancer (GIM10-CONSENT)

Breast cancer is the most common form of cancer among women. For patients candidated for adjuvant chemotherapy and endocri...

Active, not recruiting
Breast Cancer
Drug: Anastrozole or Letrozole or Exemestane

Phase 3

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy

Roma, RM, Italy and 73 other locations

DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour activity of trastuzumab deruxtecan (T-DXd) in combination with o ...

Active, not recruiting
Metastatic Breast Cancer
Drug: Paclitaxel
Drug: Tucatinib

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Rome, Italy and 71 other locations

This study will be conducted in patients with metastatic breast cancer who have specific Fibroblast Growth Factor Receptor gene abn...

Active, not recruiting
Metastatic Breast Cancer
FGFR 1 High Amplification
Drug: Futibatinib
Drug: Futibatinib plus Fulvestrant

Phase 2

Taiho Pharma
Taiho Pharma

Roma, Italy and 36 other locations

This study to learn more about olaparib and olaparib plus durvalumab combination therapy and also to better understand the studied disease, breast...

Active, not recruiting
Breast Cancer
Combination Product: Neoadjuvant combination therapy with olaparib plus durvalumab
Drug: Neoadjuvant Olaparib monotherapy group

Phase 2

AstraZeneca
AstraZeneca

Roma, Italy and 61 other locations

A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....

Enrolling
Advanced Breast Cancer
Drug: Fulvestrant
Drug: ARV-471

Phase 3

Pfizer
Pfizer

Roma, Lazio, Italy and 324 other locations

medicines for the potential treatment of advanced or metastatic breast cancer.This study is seeking participants who have breast...

Enrolling
Breast Cancer
Drug: ARV-471
Drug: Abemaciclib

Phase 1, Phase 2

Pfizer
Pfizer

Roma, Lazio, Italy and 40 other locations

look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...

Active, not recruiting
HER2-positive Early Breast Cancer
Breast Cancer
Drug: Pertuzumab
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

Rome, Italy and 147 other locations

medicines for the potential treatment of advanced or metastatic breast cancer.This study is seeking participants who have breast...

Enrolling
Breast Cancer
Drug: ARV-471
Drug: Ribociclib

Phase 1, Phase 2

Pfizer
Pfizer

Roma, Lazio, Italy and 43 other locations

of trastuzumab + Alpelisib +/- fulvestrant versus trastuzumab + chemotherapy in patients with PIK3CA mutated previously treated HER2+ Advanced Breast...

Active, not recruiting
Advanced Breast Cancer
Drug: Vinorelbine
Drug: Alpelisib

Phase 3

Spanish Breast Cancer Research Group (GEICAM)

Roma, Italy and 105 other locations

how treatment with Fulvestrant (FASLODEX) or Anastrozole (ARIMIDEX) effects disease progression for women with locally advanced or metastatic breast...

Active, not recruiting
Hormone Receptor Positive Breast Cancer
Drug: arimidex 1mg
Drug: faslodex dummy

Phase 3

AstraZeneca
AstraZeneca

Roma, Italy and 118 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems